Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy

Tarun Podder, Tithi Biswas, Min Yao, Yuxia Zhang, Ellen Kim, Rodney J. Ellis, Simon S. Lo, Mitchell Machtay

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Aim: The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.

Materials & methods: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm3 of chest wall and 1-10 cm3 of ribs.

Results: Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm3 of chest wall and 50.4 Gy to 1 cm3 of rib. Nine patients had more than 30 Gy dose to 30 cm3 of chest wall. No rib bone fracture was found.

Conclusion: No correlations of chest wall pain and volume of irradiation were found.

Original languageEnglish (US)
Pages (from-to)2311-2317
Number of pages7
JournalFuture Oncology
Volume10
Issue number15
DOIs
StatePublished - Dec 1 2014

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy'. Together they form a unique fingerprint.

Cite this